Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:55 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 433–456 of 7,882 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non intervention study Clear all

Conditions: Phobic Disorders, Dental Anxiety, Treatment Outcome
Interventions: Exposure Therapy; Behavioral
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Diabetes Mellitus, Type 2, End Stage Renal Disease, Irritable Bowel Syndrome
Interventions: None (Observational); Other
Lead sponsor: Indiana University; Other
Eligibility: 12 Years to 99 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Chronic Kidney Disease Stage 3
Interventions: CKD-Question Prompt Sheet; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 2
States / cities: Chicago, Illinois • Maywood, Illinois

Conditions: Bone Pain in Stage I - III Breast Cancer
Interventions: Naproxen, Loratadine, Pegfilgrastim, Chemotherapy; Drug · Biological
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 100 Years · Female only
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 83
States / cities: Muscle Shoals, Alabama • Anaheim, California • Fullerton, California + 78 more

Conditions: Asthma, Allergies
Interventions: Bronchoscopy, Segmental Allergen Challenge and Bronchoalveolar Lavage, Phlebotomy; Biological · Procedure
Lead sponsor: Andrew D. Luster, M.D.,Ph.D.; Other
Eligibility: 18 Years to 50 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Infection Due to Resistant Organism
Interventions: Fecal Microbiota Transplant (FMT), Bowel preparation, Stool or perirectal swab sampling, Fasting; Biological · Procedure · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Chronic Pain
Interventions: SUMMIT, control; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 4
States / cities: West Haven, Connecticut • Leeds, Massachusetts • Philadelphia, Pennsylvania + 1 more

Conditions: Adolescent Obesity, Adolescent Overweight, Diet, Healthy
Interventions: Intervention; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 14 Years to 17 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Head and Neck Cancer
Interventions: BRIGHT, Active Control; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Smoking
Interventions: smoking cessation aides, Twitter; Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 59 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 2
States / cities: Irvine, California

Conditions: Arthritis, Rheumatoid
Interventions: CP-690,550, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 795 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 46
States / cities: Huntsville, Alabama • Jonesboro, Arkansas • Palo Alto, California + 41 more

Conditions: Acute Coronary Syndrome
Interventions: Not listed
Lead sponsor: St. Joseph's Hospital, Florida; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Pregnancy
Interventions: Gift card to be used for contraceptives that is valued at 50% of cost of name-brand IUD (August 26, 2018-March 3, 2019), Gift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-March 31, 2023); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 4,633 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2028
U.S. locations: 9
States / cities: Ann Arbor, Michigan • Detroit, Michigan • Ferndale, Michigan + 6 more

Conditions: Non-small Cell Lung Cancer
Interventions: Archival tissue specimen and immunohistochemistry staining; Other
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years and older
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Miami, Florida • Florence, South Carolina

Conditions: Violence in Adolescence
Interventions: Multi-level Violence Prevention Intervention - Boys, Multi-level Violence Prevention Intervention - Caregivers; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 11 Years to 14 Years · Male only
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Spinal Cord Injuries
Interventions: eHealth Intervention, Active Control Condition; Other
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Anemia, Diabetes, Heart Disease, High Blood Pressure, Hypotension, Metabolic Diseases, Respiratory Diseases
Interventions: Non invasive peripheral blood monitoring; Device
Lead sponsor: Cnoga Medical Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant
Interventions: Etoposide; Oral, 50 Mg, Focused ultrasound with neuro-navigator-controlled sonication; Drug · Device
Lead sponsor: Columbia University; Other
Eligibility: 4 Years to 21 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy, Sicca Syndrome, Sjögren's Syndrome
Interventions: Biopsy; Procedure
Lead sponsor: Biogen; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 4
States / cities: Hartford, Connecticut • Boston, Massachusetts • Philadelphia, Pennsylvania + 1 more

Conditions: Anemia
Interventions: INTERCEPT Blood System for Red Blood Cells, Conventional (Control); Device
Lead sponsor: Cerus Corporation; Industry
Eligibility: 4 Years and older
Enrollment: 692 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 12
States / cities: Phoenix, Arizona • New Haven, Connecticut • Jacksonville, Florida + 8 more

Conditions: Smoking Cessation, Electronic Cigarette Use
Interventions: Varenicline, Nicotine patch, Dual Focused Cessation Counseling, Smoking Focused Cessation Counseling, Counseling Intensity: 1 Session, Counseling Intensity: 4 Sessions; Drug · Behavioral · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 21 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Metastatic Breast Cancer, Triple Negative Breast Cancer
Interventions: cMet RNA CAR T cells; Biological
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Large-cell Lymphoma
Interventions: Rapcabtagene autoleucel (YTB323); Biological
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Polycystic Ovary Syndrome, Obesity
Interventions: Weight loss; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2017
U.S. locations: 1
States / cities: Richmond, Virginia

Search by objective public record fields.

Smartphone-Based Exposure Treatment for Dental Anxiety

Drug Interaction Potential of Pro-Inflammatory Conditions

Empowering Veterans to Communicate With Healthcare Providers

NOLAN: Naproxen or Loratadine and Neulasta

Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma

FMT for MDRO Colonization After Infection in Renal Transplant Recipients

Development/Testing of SUMMIT: a Tool to Help Patients Manage Pain While Tapering Opioids

Helping Educate and Advance Learning Through Healthy Bite-Sized Eating Strategies

Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) 2.0

Twitter-enabled Mobile Messaging for Smoking Relapse Prevention

A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications

Study to Validate Simple Acute Coronary Syndrome Score

Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1

A Study of Prevalence of HER3 Expression in Non-Small Cell Lung Cancer

A Multi-level Approach to Violence Prevention Among African American Adolescents

Evaluation of an eHealth System to Reduce Depression and Increase Resilience After SCI

A Comparative Clinical Trial of the TensorTip, a Novel Non Invasive Device for Measurement Blood Parameters

FUS Etoposide for DMG

A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome

INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections

The Avenues Study: Dual Use Cessation

cMet CAR RNA T Cells Targeting Breast Cancer

CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)

Insulin and the Polycystic Ovary Syndrome--Weight Reduction Study